Showing results (31-40 of 46) with videos related to
Sort By:
Pageof 5
Fertility and Sterility|March 1, 1989
Localization of transferrin and its receptor in ovarian follicular cells: morphologic studies in relation to follicular developmentS L Aleshire, K G Osteen, W S Maxson, et al.Cancer Research|May 15, 1994
Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cellsY L Ottaviano, J P Issa, F F Parl, et al.Cancer|April 15, 1994
p53 gene mutations and steroid receptor status in breast cancer. Clinicopathologic correlations and prognostic assessmentM Caleffi, M W Teague, R A Jensen, et al.Molecular Endocrinology (Baltimore, Md.)|July 1, 1997
High-mobility group (HMG) protein HMG-1 and TATA-binding protein-associated factor TAF(II)30 affect estrogen receptor-mediated transcriptional activationC S Verrier, N Roodi, C J Yee, et al.Cancer|July 10, 2001
No elevation in long-term breast carcinoma risk for women with fibroadenomas that contain atypical hyperplasiaB A Carter, D L Page, P Schuyler, et al.Cancer|April 3, 1999
Estrogen replacement therapy in women with a history of proliferative breast diseaseW D Dupont, D L Page, F F Parl, et al.American Journal of Human Genetics|June 19, 2001
Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancerM D Ritchie, L W Hahn, N Roodi, et al.Cancer Research|September 2, 2000
Aberrant methylation of the estrogen receptor and E-cadherin 5' CpG islands increases with malignant progression in human breast cancerS J Nass, J G Herman, E Gabrielson, et al.Journal of the National Cancer Institute|March 15, 1995
Estrogen receptor gene analysis in estrogen receptor-positive and receptor-negative primary breast cancerN Roodi, L R Bailey, W Y Kao, et al.The New England Journal of Medicine|July 7, 1994
Long-term risk of breast cancer in women with fibroadenomaW D Dupont, D L Page, F F Parl, et al.Pageof 5